Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Tuesday, September 1, 2026

Back to today

EVC Update

EVC reported a solid second quarter and outlook.

EVC $727M
Nat Stewart - Stock Picking Newsletter 15 clicks

From X

@ActAccordingly

PAA Research on X

Many. High level, the $AIRS quarter wasn't as good as hoped, but certainly not something that warranted the kind of response it received. Top of the funnel interest in lipo slowed in June/July. I have my own thesis on the potential impact of the world cup, given the shift in consumer interest in that procedure towards the latina community over the past 15-years. Only time will tell if that's right. Either way, the business is stable and now oriented for growth. Adding new procedures (eye bleph and alloclae) significantly expands $AIRS ability to serve the GLP-1 crowd. My expectation is we'll see the bank deal completed before they report 3Q26 and that could coincide with the announcement of site expansion in early 2027. The growth opportunity here remains monumental. $AIRS has massive inherent operating leverage to improved site level utilization. There was some fast money and retail involved here (clearly!), but this is about the company improving the marketing funnel in absolute lead generation and conversion, driving site level utilization, and expanding on a de novo basis. That's the recipe and obsessing about whether growth should have been 2-4% higher for 2Q26 in that context is irrelevant. This is a business that can be 3-5x the size and still have a runway for growth.
@eriksen_tim 1 click

Tim Eriksen on X

Is $EVC is a classic case of thesis drift for its investors? It was all about sequential hypergrowth (with a supposed SOTP margin of safety). Mgmt said Q3 will be below Q2. Now the thesis is about strong year over year growth. What happens in a few quarters when year over year growth is gone, or is low single digits? Is this really a seasonal business? For me it was a small position due to the nature of the situation. Q2 growth was lighter than I expected so I was selling after hours and have fully exited.
@BlueDuckCap 1 click

BDC on X

$XGN remains a top holding for us. Even after the big move higher post a beat and raise Q2, the shares trade for a material discount versus comps. The discount is silly. Especially when we consider that they are launching a new marker for Myositis. XGN tells us that Rheumatologists are BY FAR requesting a precise diagnostic for Myositis more than any other condition. The reason is because Myositis is treatable if caught early, but problematic if not. "this is the #1 asked for product amongst our rheumatologists clinical base... it's not even close to the #2 asked for offering" $XGN trades for 2x 2026 revenues. Comps go for 10x.

Investor Letters

All letters

The Verra Sneerer (NASDAQ:VRRM)

Verra Mobility renewed Hertz tolling management for five years. AutoKinex lets rental customers buy tolling, fuel and protection products…

VRRM $536M
The Oak Bloke 6 clicks
LWAY · long

Lifeway Foods INC

Lifeway Foods holds 95% market share in kefir, is growing 20% to 35%, and trades at 12 times projected 2027 earnings as its capex cycle…

LWAY $359M
Value Investors Club

Jumia

Jumia’s January 2028 $7/$15 call spread risks $1.15 for up to $6.85 if cost cuts and marketplace growth deliver adjusted EBITDA and…

JMIA $938M
Triple S Special Situations Investing 13 clicks

Stock Trade Compilation Diez

E.W. Scripps, Team Internet, Monro, doValue and Inter & Co feature as special-situation trades involving mergers, asset sales, leverage and…

SSP $292MMNRO $383M
Triple S Special Situations Investing 9 clicks

Entravision Q2 Notes

Entravision’s ATS revenue rose 230% to $182.8 million in Q2, but shares fell from above $14 to about $8 after management forecast…

EVC $727M
The Value Road 13 clicks

40 Stock Pitches (3rd-9th August)

Navient trades near 40% of tangible book as Gator Financial Partners argues private student-loan growth and restructuring can reverse its…

NAVI $902M
Capital Employed 9 clicks

Publications we follow

Every publication on this site, hand-picked.

108 publications

Newsletters 91

YouTube 4

Blogs 12

Seeking Alpha 29 of 159

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

68 accounts
Nominate an account

Investor letters we follow

78 firms

Sectors

Ordered by how often our editor reaches for them.